Sr Associate Scientist/Scientist, Cellular and Molecular Immunotherapy
bluebird bio is developing potentially transformative, one-time gene therapies for severe genetic and orphan diseases. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of new treatments for diseases with few or no clinical options. bluebird bio has two clinical stage product candidates in development, one for childhood cerebral adrenoleukodystrophy (CCALD) and one for beta-thalassemia major/sickle cell disease, and an early stage oncology program in partnership with Celgene.
Join bluebird bio’s enthusiastic and collaborative Cellular Immunotherapy team by contributing to the overall success of our novel gene-based immunotherapy approach. This new Associate Scientist will join our group to design, develop and evaluate novel cellular immunotherapy approaches for clinical applications.
- Design, develop and construct lentivirus vectors to genetically modify freshly isolated CD34+ cells and T lymphocytes.
- Expand the gene modified cells in culture.
- Design and develop flow cytometry-based assays to characterize primary CD34+ stem cells and freshly isolated T lymphocytes and following in vitro culture.
- Design and develop cell-based assays to assess the functional characteristics of genetically modified CD34+ cells and T lymphocytes.
- Prepare all technical reports needed in support of an exploratory project moving to process development.
- Exercise independent judgment in development of new methods, techniques and evaluation criteria.
- BS/MS cell biology, molecular biology immunology or related discipline with 7+ years' experience in a relevant field.
- Experience in molecular cloning.
- Experience with viral vector or vaccine production is a plus.
- Expertise in mammalian cell culture, with specific experience isolating and propagating in vitro culture of human CD34+ cells and human/mouse T lymphocytes.
- Experience with flow cytometry of primary human cells – cell sorting experience a plus.
- Experience with immune effector cell functional assays (proliferation, cytokine production, chromium release assays).
- Experience in working in animal models of adoptive immunotherapy for autoimmune disease or Oncology a plus.
- Proven ability to effectively plan and organize work activities and prioritize task completion to meet schedules and deadlines.
- Ability to work as part of a team, collaborating with members of other functional groups.
- Understanding of safe lab practices and BSL requirements.
- Excellent computer skills and experience with Microsoft Excel. Flow cytometry data analysis software desired.
- Should be highly motivated, flexible, and have excellent organizational and communication skills.
- Must be able to work both independently and as part of a multi-disciplinary team.
- Be ready to embrace the principles of the bluebird bio culture: b colorful, b cooperative, b yourself.
bluebird bio, 840 Memorial Drive, Cambridge, MA 02139 www.bluebirdbio.com
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- May 22, 2013 Drug Repurposing and Reformulation: At the Crossroads of IP, Clinical and Business Strategies
- May 8, 2013 MassBio Recognizes Marlborough as a Major Massachusetts Life Sciences Hub: City Biz List - 5/6/2013
- May 8, 2013 Marlborough commended as tech hub: MetroWest Daily News - 5/7/2013
- May 6, 2013 MassBio Recognizes Marlborough as a Major Life Sciences Hub in Massachusetts: PR.com - 5/5/2013
- May 6, 2013 Elections may have big impact on tech, biotech: Boston Globe - 5/5/2013